AXA S.A.
- SEC CIK
- 0000898427
- Latest filing
- Aug 14, 2026
SLN holding history
Silence Therapeutics plc in every 13F filed by AXA S.A., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SLN overviewAll 13F holders of SLNFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −58,624−100.0% | Sold out | Holders |
| Q2 2023 | 58,624 | $322.4K | <0.1% | −457,792−88.6% | Reduced | Holders |
| Q1 2023 | 516,416 | $3.20M | <0.1% | −125,250−19.5% | Reduced | Holders |
| Q4 2022 | 641,666 | $9.79M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 641,666 | $6.44M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 641,666 | $7.60M | <0.1% | −20,000−3.0% | Reduced | Holders |
| Q1 2022 | 661,666 | $12.6M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 661,666 | $15.8M | <0.1% | +661,666 | New | Holders |